Chengcheng Shi

411 total citations
22 papers, 261 citations indexed

About

Chengcheng Shi is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Chengcheng Shi has authored 22 papers receiving a total of 261 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 9 papers in Pulmonary and Respiratory Medicine and 7 papers in Oncology. Recurrent topics in Chengcheng Shi's work include Cerebrovascular and Carotid Artery Diseases (4 papers), Acute Ischemic Stroke Management (4 papers) and Ubiquitin and proteasome pathways (4 papers). Chengcheng Shi is often cited by papers focused on Cerebrovascular and Carotid Artery Diseases (4 papers), Acute Ischemic Stroke Management (4 papers) and Ubiquitin and proteasome pathways (4 papers). Chengcheng Shi collaborates with scholars based in China, United States and South Korea. Chengcheng Shi's co-authors include Huapeng Zhang, Yi Zhang, Dechao Jiao, Zaoqu Liu, Xinwei Han, Xueliang Zhou, Zhenqiang Sun, Yuyuan Zhang, Shuijun Zhang and Shanshan Li and has published in prestigious journals such as Environmental Science & Technology, Scientific Reports and The FASEB Journal.

In The Last Decade

Chengcheng Shi

19 papers receiving 260 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Chengcheng Shi China	8	168	93	75	56	24	22	261
Marco Basiricò Italy	8	89 0.5×	117 1.3×	75 1.0×	33 0.6×	20 0.8×	16	239
Jindan An China	10	261 1.6×	76 0.8×	48 0.6×	171 3.1×	15 0.6×	13	340
Xinping Zhong China	10	199 1.2×	57 0.6×	21 0.3×	98 1.8×	27 1.1×	25	297
Chengkai Jiang China	8	148 0.9×	63 0.7×	92 1.2×	90 1.6×	23 1.0×	8	261
Jun Xue China	9	150 0.9×	65 0.7×	32 0.4×	89 1.6×	29 1.2×	26	268
Yelong Chen China	9	168 1.0×	79 0.8×	44 0.6×	87 1.6×	13 0.5×	11	274
Isabel Weinhäuser Brazil	5	110 0.7×	49 0.5×	32 0.4×	49 0.9×	18 0.8×	19	217
L. T. Busund Norway	7	149 0.9×	80 0.9×	47 0.6×	112 2.0×	10 0.4×	7	256
Dazhi Fu China	7	202 1.2×	47 0.5×	143 1.9×	152 2.7×	16 0.7×	11	290
Moubin Lin China	10	135 0.8×	109 1.2×	49 0.7×	118 2.1×	13 0.5×	18	316

Countries citing papers authored by Chengcheng Shi

Since Specialization

Citations

This map shows the geographic impact of Chengcheng Shi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chengcheng Shi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chengcheng Shi more than expected).

Fields of papers citing papers by Chengcheng Shi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chengcheng Shi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chengcheng Shi. The network helps show where Chengcheng Shi may publish in the future.

Co-authorship network of co-authors of Chengcheng Shi

This figure shows the co-authorship network connecting the top 25 collaborators of Chengcheng Shi. A scholar is included among the top collaborators of Chengcheng Shi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chengcheng Shi. Chengcheng Shi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Tian, Shen, et al.. (2025). Menin inhibitor MI-503 exhibits potent anti-cancer activity in osteosarcoma. Scientific Reports. 15(1). 7059–7059.

Geng, Ningbo, Shuangshuang Chen, Yangyang Bian, et al.. (2025). Uncovering Mitochondrial Defects Induced by Chemicals: A Case Study of Low-Dose Medium-Chain Chlorinated Paraffin Exposure. Environmental Science & Technology. 59(18). 8972–8983. 1 indexed citations

Shi, Chengcheng, Dongjing Yang, Yang Bai, et al.. (2025). ATF6 Alleviates Endothelial Inflammation Following Extended Hepatectomy Through Inhibition of TRIM10 / NF ‐ κB Signaling. The FASEB Journal. 39(16). e70933–e70933.

Li, Fang, Chengcheng Shi, Rong Cao, et al.. (2025). Medium-Chain Chlorinated Paraffins Induced Reproductive Toxicity in Female Rats by Interfering with Oocyte Meiosis and Triggering DNA Damage. Environmental Science & Technology. 59(23). 11455–11467. 1 indexed citations

Hu, Bowen, Jie Gao, Jihua Shi, et al.. (2022). Necroptosis throws novel insights on patient classification and treatment strategies for hepatocellular carcinoma. Frontiers in Immunology. 13. 970117–970117. 6 indexed citations

Li, Tengfei, et al.. (2022). Clinical Study of High-Resolution C-Arm CT in Mechanical Recanalization and Stent Implantation for Chronic Cerebral Artery Occlusion. Neurology India. 70(2). 694–698. 2 indexed citations

Gao, Jie, et al.. (2022). The role of NCAPG in various of tumors. Biomedicine & Pharmacotherapy. 155. 113635–113635. 21 indexed citations

Sun, Yu, et al.. (2022). Clinical evaluation of high-resolution cone-beam computed tomography for the implantation of flow-diverter stents in intracranial aneurysms. Journal of Clinical Neuroscience. 103. 14–19. 3 indexed citations

Shi, Chengcheng, et al.. (2022). Effects of ABCB1 DNA methylation in donors on tacrolimus blood concentrations in recipients following liver transplantation. British Journal of Clinical Pharmacology. 88(10). 4505–4514. 6 indexed citations

10.

Zhao, Kun, Jie Gao, Jihua Shi, et al.. (2022). FXR1 promotes proliferation, invasion and migration of hepatocellular carcinoma in vitro and in vivo. Oncology Letters. 25(1). 22–22. 5 indexed citations

11.

Li, Tengfei, Yuting Wang, Michael R. Levitt, et al.. (2021). Application of High-Resolution Flat Detector Computed Tomography in Stent Implantation for Intracranial Atherosclerotic Stenosis. Frontiers in Neuroscience. 15. 655594–655594. 5 indexed citations

12.

Liu, Zaoqu, Yuyuan Zhang, Chengcheng Shi, et al.. (2021). A novel immune classification reveals distinct immune escape mechanism and genomic alterations: implications for immunotherapy in hepatocellular carcinoma. Journal of Translational Medicine. 19(1). 5–5. 76 indexed citations

13.

Huang, Runzhi, Chengcheng Shi, Penghui Yan, et al.. (2021). Construction and validation of nomograms for non‑metastatic Ewing sarcoma: A prognostic factor analysis based on the SEER database. Oncology Letters. 22(5). 777–777. 2 indexed citations

14.

Shi, Chengcheng, Yun‐Qing Song, Rong-Jing He, et al.. (2020). Rapalogues as hCES2A Inhibitors: In Vitro and In Silico Investigations. European Journal of Drug Metabolism and Pharmacokinetics. 46(1). 129–139. 2 indexed citations

15.

Shi, Chengcheng, Tianran Chen, Qihua Zhang, et al.. (2020). Inhibition of human thrombin by the constituents of licorice: inhibition kinetics and mechanistic insights through in vitro and in silico studies. RSC Advances. 10(7). 3626–3635. 8 indexed citations

16.

Shi, Chengcheng, Huapeng Zhang, Penglei Wang, et al.. (2019). PROTAC induced-BET protein degradation exhibits potent anti-osteosarcoma activity by triggering apoptosis. Cell Death and Disease. 10(11). 815–815. 40 indexed citations

17.

Zhang, Yi, et al.. (2017). Inhibition of Mcl-1 enhances Pevonedistat-triggered apoptosis in osteosarcoma cells. Experimental Cell Research. 358(2). 234–241. 11 indexed citations

18.

Zhang, Yi, et al.. (2016). MLN4924 suppresses neddylation and induces cell cycle arrest, senescence, and apoptosis in human osteosarcoma. Oncotarget. 7(29). 45263–45274. 46 indexed citations

19.

Zhang, Yi, Ke Yao, Chengcheng Shi, et al.. (2015). 244-MPT overcomes gefitinib resistance in non-small cell lung cancer cells. Oncotarget. 6(42). 44274–44288. 14 indexed citations

20.

Zhang, Yi, Ke Yao, Chengcheng Shi, et al.. (2015). 244-MPT over comes gefitinib resistance in non-small cell lung cancer cells. PubMed Central. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact